Elanco Animal Health (NYSE:ELAN)报告其季度每股收益为$0.14，低于分析师预期的$0.15，差距为6.67%。这一结果较去年同期的$0.08每股盈利增长了75%。公司报告季度销售额为$10.2亿美元，超过分析师预期的$10.1亿美元，高出0.98%。但这一结果较去年同期的$10.3亿销售额减少了1.45%。
以上内容来自Benzinga Earnings专栏，原文如下：
Elanco Animal Health (NYSE:ELAN) reported quarterly earnings of $0.14 per share which missed the analyst consensus estimate of $0.15 by 6.67 percent. This is a 75 percent increase over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $1.02 billion which beat the analyst consensus estimate of $1.01 billion by 0.98 percent. This is a 1.45 percent decrease over sales of $1.03 billion the same period last year.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。